102 related articles for article (PubMed ID: 37331637)
1. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.
Tavakoli Dargani Z; Singla DK
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H460-H471. PubMed ID: 31172809
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC.
Xu F; Zang T; Chen H; Zhou C; Wang R; Yu Y; Shen L; Qian J; Ge J
Cell Signal; 2024 Jan; 113():110937. PubMed ID: 37871668
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV Alleviates Doxorubicin-Induced Cardiotoxicity by Inhibiting Cardiomyocyte Pyroptosis through the SIRT1/NLRP3 Pathway.
Tian W; Zhang P; Yang L; Song P; Zhao J; Wang H; Zhao Y; Cao L
Am J Chin Med; 2024; 52(2):453-469. PubMed ID: 38490806
[TBL] [Abstract][Full Text] [Related]
5. 7,8,3'-Trihydroxyflavone prevents doxorubicin-induced cardiotoxicity and mitochondrial dysfunction via activating Akt signaling pathway in H9c2 cells.
Zhao J; Yu HQ; Ge FQ; Zhang MR; Song YC; Guo DD; Li QH; Zhu H; Hang PZ
Cell Signal; 2023 Dec; 112():110924. PubMed ID: 37838311
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy.
Lin ZH; Xiang HQ; Yu YW; Xue YJ; Wu C; Lin C; Ji KT
FASEB J; 2024 May; 38(10):e23677. PubMed ID: 38775792
[TBL] [Abstract][Full Text] [Related]
7. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
[TBL] [Abstract][Full Text] [Related]
8. TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy.
Guo Z; Tang N; Liu FY; Yang Z; Ma SQ; An P; Wu HM; Fan D; Tang QZ
J Cell Mol Med; 2020 Sep; 24(18):10913-10923. PubMed ID: 33140921
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of secretory APE1/Ref-1 on doxorubicin-induced cardiotoxicity via suppression of ROS and p53 pathway.
An SY; Jin SA; Seo HJ; Lee YR; Kim S; Jeon BH; Jeong JO
ESC Heart Fail; 2024 Apr; 11(2):1182-1193. PubMed ID: 38286792
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic study of Huangqi Guizhi Wuwu decoction amelioration of doxorubicin-induced cardiotoxicity by reducing oxidative stress and inhibiting cellular pyroptosis.
Chen Y; Xu M; Liu XM; Wang JX; Sun MF; Song JX; Guan P; Ji ES; Wang N
Biomed Pharmacother; 2024 Jun; 175():116653. PubMed ID: 38688172
[TBL] [Abstract][Full Text] [Related]
11. Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In Vivo.
Gao J; Chen T; Zhao D; Zheng J; Liu Z
PLoS One; 2016; 11(12):e0168219. PubMed ID: 27973574
[TBL] [Abstract][Full Text] [Related]
12. Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action.
Pharoah BM; Zhang C; Khodade VS; Keceli G; McGinity C; Paolocci N; Toscano JP
Redox Biol; 2023 Apr; 60():102625. PubMed ID: 36773545
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme Q10 mitigates cadmium cardiotoxicity by downregulating NF-κB/NLRP3 inflammasome axis and attenuating oxidative stress in mice.
Antar SA; Abdo W; Helal AI; Abduh MS; Hakami ZH; Germoush MO; Alsulimani A; Al-Noshokaty TM; El-Dessouki AM; ElMahdy MK; Elgebaly HA; Al-Karmalawy AA; Mahmoud AM
Life Sci; 2024 Jul; 348():122688. PubMed ID: 38710284
[TBL] [Abstract][Full Text] [Related]
14. USP36-mediated PARP1 deubiquitination in doxorubicin-induced cardiomyopathy.
Wang D; Jiang Z; Kan J; Jiang X; Pan C; You S; Chang R; Zhang J; Yang H; Zhu L; Gu Y
Cell Signal; 2024 May; 117():111070. PubMed ID: 38307305
[TBL] [Abstract][Full Text] [Related]
15. Matrine attenuating cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity through improved mitochondrial membrane potential and activation of mitochondrial respiratory chain Complex I pathway.
Erfu C; Li L; Weiting Q; Tao C; Liwei M; Hemin Y; Junkun L
Biomed Pharmacother; 2024 Apr; 173():116464. PubMed ID: 38503242
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective Potential of Cymbopogon citratus Essential Oil against Isoproterenol-induced Cardiomyocyte Hypertrophy: Possible Involvement of NLRP3 Inflammasome and Oxidative Phosphorylation Complex Subunits.
Ding XY; Zhang H; Qiu YM; Xie MD; Wang H; Xiong ZY; Li TT; He CN; Dong W; Tang XL
Curr Med Sci; 2024 Apr; 44(2):450-461. PubMed ID: 38639827
[TBL] [Abstract][Full Text] [Related]
17. Diazoxide attenuates DOX-induced cardiotoxicity in cultured rat myocytes.
Guven C; Taskin E; Aydın Ö; Kaya ST; Sevgiler Y
Biotech Histochem; 2024 Apr; 99(3):113-124. PubMed ID: 38439686
[TBL] [Abstract][Full Text] [Related]
18. PLCE1 enhances mitochondrial dysfunction to promote GSDME-mediated pyroptosis in doxorubicin-induced cardiotoxicity.
Tuersuntuoheti M; Peng F; Li J; Zhou L; Gao H; Gong H
Biochem Pharmacol; 2024 May; 223():116142. PubMed ID: 38499110
[TBL] [Abstract][Full Text] [Related]
19. AKT2 deficiency alleviates doxorubicin-induced cardiac injury via alleviating oxidative stress in cardiomyocytes.
Chen J; Xu X; Shao Y; Bian X; Li R; Zhang Y; Xiao Y; Lu M; Jiang Q; Zeng Y; Yan F; Ye J; Li Z
Int J Biochem Cell Biol; 2024 Apr; 169():106539. PubMed ID: 38290690
[TBL] [Abstract][Full Text] [Related]
20. Targeting autophagy with SAR405 alleviates doxorubicin-induced cardiotoxicity.
Sun X; Du J; Meng H; Liu F; Yang N; Deng S; Wan H; Ye D; Song E; Zeng H
Cell Biol Toxicol; 2023 Dec; 39(6):3255-3267. PubMed ID: 37768392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
